Last reviewed · How we verify
Qutenza exposure
At a glance
| Generic name | Qutenza exposure |
|---|---|
| Also known as | Capsaicin |
| Sponsor | Astellas Pharma Europe Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Pain Biomarker Study (PHASE1)
- Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke (PHASE2)
- The Influence of Capsaicin Gel During Exercise Within the Heat (PHASE4)
- Cough Desensitization Therapy for Cough Hypersensitivity Syndrome (EARLY_PHASE1)
- Effect of Electronic Cigarette Use on Cough Reflex Sensitivity (PHASE4)
- Cough Desensitization Therapy: Pilot 2 (PHASE1)
- Normal Breathing and Swallowing in Healthy Volunteers (PHASE1, PHASE2)
- The Effect of Physical Exercise in a Cold Air Environment on Normal Volunteers and Asthmatic Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |